| Long-term real-world effectiveness and safety of ustekinumab in Crohn’s disease patients: the SUSTAIN study M Chaparro, I Baston-Rey, E Fernández-Salgado, J González García, ... Inflammatory Bowel Diseases 28 (11), 1725-1736, 2022 | 44 | 2022 |
| Autoeficacia académica, apoyo social académico, bienestar escolar y su relación con el rendimiento académico en estudiantes universitarios JO González-Cantero, JÁ Morón-Vera, VH González-Becerra, ... Psicumex 10 (2), 95-113, 2020 | 35 | 2020 |
| Prognosis of patients with ulcerative colitis in sustained remission after thiopurines withdrawal E Moreno-Rincón, JM Benítez, FJ Serrano-Ruiz, JM Vázquez-Morón, ... Inflammatory bowel diseases 21 (7), 1564-1571, 2015 | 31 | 2015 |
| Accurate cut-offs for predicting endoscopic activity and mucosal healing in Crohn's disease with fecal calprotectin JM Vázquez-Morón, H Pallarés-Manrique, FH Machancoses, ... Revista Española de Enfermedades Digestivas 109 (2), 130-136, 2017 | 29 | 2017 |
| Crohn’s-like disease in a patient with common variable immunodeficiency treated with azathioprine and adalimumab JM Vázquez-Morón, H Pallarés-Manrique, IJ Martín-Suárez, ... Rev Esp Enferm Dig 105 (5), 299-302, 2013 | 26 | 2013 |
| Effectiveness and Safety of the Switch from Remicade® to CT-P13 in Patients with Inflammatory Bowel Disease M Chaparro, A Garre, MF Guerra Veloz, JM Vázquez Morón, ... Journal of Crohn's and Colitis 13 (11), 1380-1386, 2019 | 24 | 2019 |
| Switching from reference infliximab to CT-P13 in patients with inflammatory bowel disease: results of a multicenter study after 12 months MF Guerra-Veloz, JM Vázquez-Morón, M Belvis-Jiménez, ... Revista Española de Enfermedades Digestivas 110 (9), 564-570, 2018 | 16 | 2018 |
| Ustekinumab in Crohn’s disease: real-world outcomes and predictors of response L Lorenzo González, T Valdés Delgado, JM Vázquez Morón, ... Revista Española de Enfermedades Digestivas, 114 (5), 272-279., 2022 | 15 | 2022 |
| Real-World evidence of tofacinitib in ulcerative colitis: short and long-term effectiveness and safety M Chaparro, D Acosta, C Rodríguez, F Mesonero, M Vicuña, ... Official journal of the American College of Gastroenterology| ACG, 10.14309, 2022 | 9 | 2022 |
| Enfermedad de Crohn-like en un paciente con inmunodeficiencia común variable tratada con azatioprina y adalimumab JM Vázquez-Morón, H Pallarés-Manrique, IJ Martín-Suárez, ... Revista Española de Enfermedades Digestivas 105 (5), 299-302, 2013 | 9 | 2013 |
| Efficacy and safety of tofacitinib in the treatment of ulcerative colitis: real-life experience in Andalusia AH Martínez, PN Hernández, MDMM Rodríguez, ML Sáez, RO Martín, ... Revista espanola de enfermedades digestivas 114 (9), 516-521, 2022 | 8 | 2022 |
| Brote de dermatofitosis en región de cabeza y cuello asociadas al rasurado en peluquerías: estudio descriptivo multicéntrico de una serie de casos L Bascón, JI Galvañ, I López-Riquelme, PJ Navarro-Guillamón, JM Morón, ... Actas Dermo-Sifiliográficas 114 (5), 371-376, 2023 | 7 | 2023 |
| Utilidad de la calprotectina fecal en la enfermedad inflamatoria intestinal JMV Morón, FA Arias, HP Manrique Revista andaluza de patología digestiva 40 (2), 70-78, 2017 | 6 | 2017 |
| Managing iron deficiency and iron deficiency anemia in inflammatory bowel disease. The results of the “Gestiona hierro-EII” survey F Casellas-Jorda, I Vera Mendoza, M Barreiro-de Acosta, ... Rev Esp Enferm Dig 110 (3), 172-8, 2018 | 5 | 2018 |
| Manejo del déficit de hierro y la anemia ferropénica en la enfermedad inflamatoria intestinal. Resultados de la encuesta" Gestiona Hierro-EII" F Casellas-Jordá, I Vera-Mendoza, M Barreiro-de-Acosta, ... Revista Española de Enfermedades Digestivas 110 (3), 172-178, 2018 | 5 | 2018 |
| Using interpretable machine learning to identify baseline predictive factors of remission and drug durability in Crohn’s disease patients on ustekinumab M Chaparro, I Baston-Rey, E Fernández Salgado, J González García, ... Journal of clinical medicine 11 (15), 4518, 2022 | 3 | 2022 |
| Ileum endometriosis and Crohn's disease A Correia-Varela-Almeida, JM Vázquez-Morón, E Ortiz-López Medicina clinica 151 (11), e65-e66, 2018 | 3 | 2018 |
| Effectiveness and safety of ustekinumab dose escalation in Crohn’s disease: a multicenter observational study RVO Martín, JMV Morón, MMM Rodríguez, ML Sáez, ÁH Martínez, ... Revista Española de Enfermedades Digestivas 115 (12), 686-692, 2023 | 2 | 2023 |
| P545 Safety of ustekinumab in pregnant patients with inflammatory bowel disease and in their offspring: results from the DUMBO registry of GETECCU M Chaparro, A Gutierrez, C Calvino-Suarez, JM Huguet, M Calvo, ... Journal of Crohn's and Colitis 16 (Supplement_1), i491-i493, 2022 | 2 | 2022 |
| P478 Effectiveness of ustekinumab dose escalation in Crohn’s disease patients with insufficient response to standard-dose subcutaneous maintenance therapy: an observational … R Olmedo-Martín, MDM Martín-Rodríguez, L Lorenzo-González, ... Journal of Crohn's and Colitis 15 (Supplement_1), S467-S468, 2021 | 2 | 2021 |
